CN105727035A - 一种含艾叶的治疗结节性红斑的中药组合物及其制备方法 - Google Patents
一种含艾叶的治疗结节性红斑的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN105727035A CN105727035A CN201610196458.8A CN201610196458A CN105727035A CN 105727035 A CN105727035 A CN 105727035A CN 201610196458 A CN201610196458 A CN 201610196458A CN 105727035 A CN105727035 A CN 105727035A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine composition
- folium artemisiae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 58
- 239000000203 mixture Substances 0.000 title claims abstract description 47
- 206010015226 Erythema nodosum Diseases 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 239000009670 cang er zi wan Substances 0.000 claims abstract description 20
- 239000010231 banlangen Substances 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 239000000463 material Substances 0.000 claims abstract description 6
- 239000000843 powder Substances 0.000 claims description 11
- 239000012567 medical material Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 7
- 239000004615 ingredient Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 239000002671 adjuvant Substances 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 238000005202 decontamination Methods 0.000 claims description 4
- 230000003588 decontaminative effect Effects 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 4
- 239000008213 purified water Substances 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 19
- 239000008280 blood Substances 0.000 abstract description 12
- 210000004369 blood Anatomy 0.000 abstract description 11
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 4
- 208000026435 phlegm Diseases 0.000 abstract description 4
- 244000025254 Cannabis sativa Species 0.000 abstract description 2
- 241000931705 Cicada Species 0.000 abstract description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 2
- 241001071917 Lithospermum Species 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 241000218671 Ephedra Species 0.000 abstract 1
- 241001598107 Imperata Species 0.000 abstract 1
- 241001180876 Saposhnikovia Species 0.000 abstract 1
- 241000951473 Schizonepeta Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 10
- 231100000614 poison Toxicity 0.000 description 10
- 239000003440 toxic substance Substances 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 208000010201 Exanthema Diseases 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 201000005884 exanthem Diseases 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 230000007803 itching Effects 0.000 description 4
- 208000037920 primary disease Diseases 0.000 description 4
- 206010037844 rash Diseases 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 3
- 244000192528 Chrysanthemum parthenium Species 0.000 description 3
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 208000013219 diaphoresis Diseases 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 235000008384 feverfew Nutrition 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 240000000774 Cunila origanoides Species 0.000 description 2
- 235000018274 Cunila origanoides Nutrition 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 235000014866 Dictamnus albus Nutrition 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241001050829 Arnebia guttata Species 0.000 description 1
- 235000010894 Artemisia argyi Nutrition 0.000 description 1
- 208000027496 Behcet disease Diseases 0.000 description 1
- 208000009137 Behcet syndrome Diseases 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241001000583 Cryptotympana atrata Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000723281 Ephedra equisetina Species 0.000 description 1
- 241000218670 Ephedraceae Species 0.000 description 1
- 241001278898 Glycyrrhiza inflata Species 0.000 description 1
- 241000334160 Isatis Species 0.000 description 1
- 206010025280 Lymphocytosis Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 241001180873 Saposhnikovia divaricata Species 0.000 description 1
- 206010056876 Septal panniculitis Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010061372 Streptococcal infection Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 240000006064 Urena lobata Species 0.000 description 1
- 235000015414 Urena lobata Nutrition 0.000 description 1
- 206010047115 Vasculitis Diseases 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 244000030166 artemisia Species 0.000 description 1
- 230000006472 autoimmune response Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940127234 oral contraceptive Drugs 0.000 description 1
- 239000003539 oral contraceptive agent Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 210000000264 venule Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/538—Schizonepeta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于中药技术领域,涉及一种含艾叶的治疗结节性红斑的中药组合物及其制备方法。该中药组合物由以下重量份数的原料制备而成:艾叶1925份、防风1822份、白茅根1620份、苍耳子1622份、荆芥1117份、蝉蜕1115份、板蓝根1319份、麻黄1216份、白鲜皮1014份、紫草814份、蒲公英813份和甘草711份。本发明中药组合物具有清热解毒、活血化瘀、软坚散结、祛风散寒和除湿化痰之功效,治疗结节性红斑具有显著疗效。
Description
技术领域
本发明属于中药技术领域,尤其涉及一种含艾叶的治疗结节性红斑的中药组合物及其制备方法。
背景技术
结节性红斑是一种发生于小腿的急性炎性皮下结节。本病好发于青年女性,以春秋季多见。结节性红斑的病因尚未明确。患者多伴有风湿病、结核病或白塞氏综合征等病,病情反复发作,缠绵难愈。
结节性红斑的致病因素很多。也比较复杂。最早报道为链球菌感染,观察发现;结节性红斑在症状发生之前,约有80%以上的患者有呼吸道感染症状,其中50%左右是溶血性链球菌引起的咽炎,扁桃体炎,一般在感染三周内发病。药物因素也可引起本病,过去一直认为磺胺,溴剂和碘剂均有可能致病,近年来发现口服避孕药物也可引发本病。
结节性红斑的发病机理,有人将其视为一种变态反应,属于迟发性变态反应范畴,但也可能与第III型变态反应有关;也有人认为其发病是由于自身免疫反应在皮肤表现的结果。本病组织病理学检查结果,为真皮和皮下组织的炎症病变。总的来说,其主要表现是血管炎,多发生在较大的小静脉血管内壁,有炎性细胞浸润及内皮细胞增生,但一般血管腔通畅,不发生闭塞,也无血栓形成。血管周围也可有炎症细胞浸润,早期以嗜中性粒细胞为主,晚期则淋巴细胞增多。
中医认为,素禀血热内蕴之体,或过食辛辣炙热,郁久化热,湿热下注凝滞血脉使气血运行不畅,瘀而成结或脾虚湿盛,阳气不足,腠理不固以致风寒湿邪乘虚而人,流注经络而成结节。
中国专利申请201310236511.9公开了一种治疗结节性红斑的药膏及其制备方法,是由:苍术100-40份,土茯苓100-40份,丹皮100-40份,赤芍100-40份,忍冬藤100-40份,黄柏100-40份,白薇100-40份,栀子100-40份,延胡索100-40份,络石藤100-40份,凡士林3000-1000份制备而成,该发明中药临床可治疗结节性红斑。该中药无毒副作用,但治愈率低。
发明内容
本发明要解决的技术问题是提供一种含艾叶的治疗结节性红斑的中药组合物及其制备方法。该中药组合物具有清热解毒、活血化瘀、软坚散结、祛风散寒和除湿化痰的功效,还具有疗效好,无毒副作用和服用方便等优点。此外,本发明还提供相应的制造工艺将该中药组合物在保证疗效的前提下制成方便易用的制剂。
为实现上述目的,本发明的采取的技术方案如下:
本发明中药组合物由以下重量份数的原料制备而成:
艾叶19-25份、防风18-22份、白茅根16-20份、苍耳子16-22份、荆芥11-17份、蝉蜕11-15份、板蓝根13-19份、麻黄12-16份、白鲜皮10-14份、紫草8-14份、蒲公英8-13份和甘草7-11份。
进一步地,所述中药组合物由以下重量份数的原料制备而成:
艾叶19份、防风18份、白茅根16份、苍耳子16份、荆芥11份、蝉蜕11份、板蓝根13份、麻黄12份、白鲜皮10份、紫草8份、蒲公英8份和甘草7份。
进一步地,所述中药组合物由以下重量份数的原料制备而成:
艾叶25份、防风22份、白茅根20份、苍耳子22份、荆芥17份、蝉蜕15份、板蓝根19份、麻黄16份、白鲜皮14份、紫草14份、蒲公英13份和甘草11份。
进一步地,所述中药组合物由以下重量份数的原料制备而成:
艾叶22份、防风份20、白茅根18份、苍耳子19份、荆芥14份、蝉蜕13份、板蓝根16份、麻黄14份、白鲜皮12份、紫草11份、蒲公英11份和甘草9份。
进一步地,所述中药组合物被制成胶囊剂、片剂、散剂、口服液、颗粒剂或丸剂。
相应地,所述中药组合物的制备方法包含下述步骤:
S1、按比例称取各味原料药材;
S2、将艾叶、防风、白茅根、苍耳子、荆芥、蝉蜕、板蓝根、麻黄、白鲜皮、紫草、蒲公英和甘草分别去杂质,洗净,烘干,粉碎成粗粉;
S3、将S2制备的各味药材粗粉混合,加入初始药材6-8倍重量的蒸馏水,煎煮2-4小时,过滤并保留滤液;再加入初始药材6-8倍重量的纯化水,煎煮2-4小时,过滤得到滤液;合并提取液,浓缩至60-70℃相对密度为1.30-1.35的中药浸膏备用;
S4、往S3所得的中药浸膏中添加辅料,利用现代通用的制剂技术制成临床需要的成品制剂。
本发明所用组分的来源、性味、归经及功效:
艾叶:为菊科植物艾的干燥叶;味辛、苦,性温,归肝、脾、肾经;温经止血,散寒止痛,调经安胎,除湿止痒,通经活络。
防风:为伞形科植物防风的干燥根;味辛、甘,性温;归膀胱、肝、脾经;解表祛风,胜湿,止痉。
白茅根:为禾本科植物白茅的干燥根茎;味甘,性寒;归肺、胃、膀胱经;凉血止血,清热利尿。
苍耳子:为菊科植物苍耳的干燥成熟带总苞的果实;味辛、苦,性温,有毒;归肺经;散风除湿,通鼻窍。
荆芥:为唇形科植物荆芥的干燥地上部分;味辛,性微温;归肺、肝经;解表散风,透疹。
蝉蜕:为蝉科昆虫黑蚱的幼虫羽化时脱落的皮壳;味甘,性寒;归肺、肝经;散风除热,利咽,透疹,退翳,解痉。
板蓝根:为十字花科植物菘蓝的干燥根;味苦,性寒;归心、胃经;清热解毒,凉血利咽。
麻黄:为麻黄科植物草麻黄、中麻黄或木贼麻黄的干燥草质茎;味辛、微苦,性温;归肺、膀胱经;发汗散寒,宣肺平喘,利水消肿。
白鲜皮:为芸香科植物白鲜的干燥根皮;味苦,性寒;归脾、胃、膀胱经;清热燥湿,祛风解毒。
紫草:为紫草科植物新疆紫草、紫草或内蒙紫草的干燥根;味甘、咸,性寒;归心、肝经;凉血,活血,解毒透疹。
蒲公英:为菊科植物蒲公英、碱地蒲公英或同属数种植物的干燥全草;味苦、甘,性寒;归肝、胃经;清热解毒,消肿散结,利尿通淋。
甘草:本品为豆科植物甘草、胀果甘草或光果甘草的干燥根。味甘,性平;归心、肺、脾、胃经;补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药。
本发明中药的组方分析:
依据中医对结节性红斑的辨证和中药材的配伍理论,结合现代人的身体素质和现代制药技术的特点,合理科学的搭配各味药材,形成本发明中药组方。本发明的组方是以艾叶为君药,散寒止痛,除湿止痒,通经活络;以防风、白茅根和苍耳子为臣药,解表祛风,清热除湿;以荆芥、蝉蜕、板蓝根、麻黄、白鲜皮、紫草和蒲公英为佐药,清热解毒,祛风透疹,消肿散结;以甘草为使药,补脾益气,调和诸药;君臣佐使诸药配合,协同促进,相辅相成,最终达到清热解毒、活血化瘀、软坚散结、祛风散寒和除湿止痒的功效,适用于结节性红斑的患者。
与现有技术相比,本发明具有如下技术优势:
1、本发明中药组合物与其他治疗治疗结节性红斑的药物相比,在祛风散寒和除湿止痒方面,具有显著的功效,临床试验结果表明,本发明中药组合物能够显著缓解和消除结节性多形红斑志愿患者的皮损症状,疗效明显优于对照组,且复发率低,在用药过程中无明显不良反应。
2、与当前治疗结节性红斑的化学治疗药物相比,本发明中药组合物的组方为纯天然药材,不良反应和副作用显著降低,且本发明中药组合物作用全面,药物治疗效果更佳,有效地解决了结节性红斑的发病根源,并提高了患者的生活质量。
3、本发明中药组合物还具有配伍科学、治愈率高、不易复发等优点。
具体实施方式
本领域技术人员应理解,以下实施例中所公开的技术代表本发明人发现的在本发明的实践中发挥良好作用的技术。然而,在所公开的具体实施方案中可以做出许多改变,并仍然获得相同或相似的结果,而不脱离本发明的精神和范围。
实施例1
本发明实施例1中药组合物由以下重量份数的原料制备而成:艾叶19份、防风18份、白茅根16份、苍耳子16份、荆芥11份、蝉蜕11份、板蓝根13份、麻黄12份、白鲜皮10份、紫草8份、蒲公英8份和甘草7份。
制备方法如下:
S1、按比例称取各味原料药材;
S2、将艾叶、防风、白茅根、苍耳子、荆芥、蝉蜕、板蓝根、麻黄、白鲜皮、紫草、蒲公英和甘草分别去杂质,洗净,烘干,粉碎成粗粉;
S3、将S2制备的各味药材粗粉混合,加入初始药材6倍重量的蒸馏水,煎煮3小时,过滤并保留滤液;再加入初始药材6倍重量的纯化水,煎煮2小时,过滤得到滤液;合并提取液,浓缩至70℃相对密度为1.35的中药浸膏备用;
S4、往S3所得的中药浸膏中添加辅料,利用现代通用的制剂技术制成胶囊,每颗胶囊含药量为0.4g。
实施例2
本发明实施例2中药组合物由以下重量份数的原料制备而成:艾叶25份、防风22份、白茅根20份、苍耳子22份、荆芥17份、蝉蜕15份、板蓝根19份、麻黄16份、白鲜皮14份、紫草14份、蒲公英13份和甘草11份。
制备方法同实施例1。
实施例3
本发明实施例3中药组合物由以下重量份数的原料制备而成:艾叶22份、防风份20、白茅根18份、苍耳子19份、荆芥14份、蝉蜕13份、板蓝根16份、麻黄14份、白鲜皮12份、紫草11份、蒲公英11份和甘草9份。
制备方法同实施例1。
实施例4
本发明实施例4中药组合物由以下重量份数的原料制备而成:艾叶20份、防风19份、白茅根17份、苍耳子18份、荆芥12份、蝉蜕12份、板蓝根14份、麻黄13份、白鲜皮11份、紫草10份、蒲公英9份和甘草8份。
制备方法同实施例1。
实施例5
本发明实施例5中药组合物由以下重量份数的原料制备而成:艾叶23份、防风21份、白茅根19份、苍耳子21份、荆芥16份、蝉蜕14份、板蓝根17份、麻黄15份、白鲜皮13份、紫草12份、蒲公英12份和甘草10份。
制备方法同实施例1。
本发明中药组合物对结节性红斑临床志愿者患者的疗效观察
一、诊断标准
参照根据合《临床皮肤病学》结节性红斑的诊断标准:
1、小腿伸侧突然发生的对称性、疼痛性鲜红色结节;
2、结节有压痛,无破溃;
3、组织病理为间隔性脂膜炎;
二、疗效标准
参照根据国家中药管理局颁布的《中医病症诊断疗效标准》确定:
治愈:红斑消退,自觉症状消失;
有效:红斑消退30%以上,自觉症状明显减轻;
无效:红斑结节无变化或有新的皮损出现。
三、临床试验
1、一般资料
将720名入选的结节性红斑临床志愿者患者随机均分成6组,每组120人,分别为治疗A-E组和对照组,各组年龄、症状等影响因素,经统计学处理,无显著性差异,符合分组条件。
2、治疗方法
试验A-E组:分别服用本发明实施例1-5制备得到的胶囊(0.4g*60粒/瓶),每日2次,每次3粒,连服4周;
对照组:服用新癀片(厦门中药厂有限公司,国药准字Z35020063,0.32g*36片/盒),一次4片,一日3次,连服4周。
3、治疗结果,如表1所示。
表1治疗效果
组别 | 例数 | 治愈(率) | 有效 | 无效 | 总有效率 |
治疗A组 | 120 | 83(69.2%) | 17 | 20 | 83.3% |
治疗B组 | 120 | 85(70.8%) | 17 | 18 | 85.0% |
治疗C组 | 120 | 87(72.5%) | 18 | 15 | 87.5% |
治疗D组 | 120 | 82(68.3%) | 19 | 19 | 84.2% |
治疗E组 | 120 | 84(70.0%) | 19 | 17 | 85.8% |
对照组 | 120 | 78(75.0%) | 21 | 21 | 82.5% |
本试验采用新癀片作为对照组,新癀片由肿节风、三七、人工牛黄、肖梵天花、珍珠层粉等中药精心提炼而成,具有清热解毒,活血化瘀,消肿止痛的功效。从治愈率和总有效率上可看出,本发明中药组合物的治愈率和总有效率均明显高于对照组,其中以治疗C组即本发明实施例3制得的中药组合物效果最好。临床实验结果证明本发明中药组合物治疗结节性红斑效果显著,具有清热解毒、活血化瘀、软坚散结、祛风散寒和除湿化痰的疗效,可作为临床治疗结节性红斑药物使用,临床推广价值高。
由于已经通过以上较佳实施例描述了本发明,在本发明的精神和/或范围内,任何针对本发明的替换/或组合来实施本发明,对于本领域的技术人员来说都是显而易见的,且包含在本发明之中。
Claims (7)
1.一种含艾叶的治疗结节性红斑的中药组合物,其特征在于,所述中药组合物由以下重量份数的原料制备而成:
艾叶19-25份、防风18-22份、白茅根16-20份、苍耳子16-22份、荆芥11-17份、蝉蜕11-15份、板蓝根13-19份、麻黄12-16份、白鲜皮10-14份、紫草8-14份、蒲公英8-13份和甘草7-11份。
2.如权利要求1所述的含艾叶的治疗结节性红斑的中药组合物,其特征在于,所述中药组合物由以下重量份数的原料制备而成:
艾叶19份、防风18份、白茅根16份、苍耳子16份、荆芥11份、蝉蜕11份、板蓝根13份、麻黄12份、白鲜皮10份、紫草8份、蒲公英8份和甘草7份。
3.如权利要求1所述的含艾叶的治疗结节性红斑的中药组合物,其特征在于,所述中药组合物由以下重量份数的原料制备而成:
艾叶25份、防风22份、白茅根20份、苍耳子22份、荆芥17份、蝉蜕15份、板蓝根19份、麻黄16份、白鲜皮14份、紫草14份、蒲公英13份和甘草11份。
4.如权利要求1所述的含艾叶的治疗结节性红斑的中药组合物,其特征在于,所述中药组合物由以下重量份数的原料制备而成:
艾叶22份、防风份20、白茅根18份、苍耳子19份、荆芥14份、蝉蜕13份、板蓝根16份、麻黄14份、白鲜皮12份、紫草11份、蒲公英11份和甘草9份。
5.如权利要求1-4任一所述的含艾叶的治疗结节性红斑的中药组合物,其特征在于,所述中药组合物被制成胶囊剂、片剂、散剂、口服液、颗粒剂或丸剂。
6.如权利要求1-4任一所述的含艾叶的治疗结节性红斑的中药组合物,其特征在于,所述中药组合物的制备方法包含下述步骤:
S1、按比例称取各味原料药材;
S2、将艾叶、防风、白茅根、苍耳子、荆芥、蝉蜕、板蓝根、麻黄、白鲜皮、紫草、蒲公英和甘草分别去杂质,洗净,烘干,粉碎成粗粉;
S3、将S2制备的各味药材粗粉混合,加入初始药材6-8倍重量的蒸馏水,煎煮2-4小时,过滤并保留滤液;再加入初始药材6-8倍重量的纯化水,煎煮2-4小时,过滤得到滤液;合并提取液,浓缩至60-70℃相对密度为1.30-1.35的中药浸膏备用;
S4、往S3所得的中药浸膏中添加辅料,利用现代通用的制剂技术制成临床需要的成品制剂。
7.一种制备如权利要求1所述的含艾叶的治疗结节性红斑的中药组合物的方法,其特征在于,包含下述步骤:
S1、按比例称取各味原料药材;
S2、将艾叶、防风、白茅根、苍耳子、荆芥、蝉蜕、板蓝根、麻黄、白鲜皮、紫草、蒲公英和甘草分别去杂质,洗净,烘干,粉碎成粗粉;
S3、将S2制备的各味药材粗粉混合,加入初始药材6-8倍重量的蒸馏水,煎煮2-4小时,过滤并保留滤液;再加入初始药材6-8倍重量的纯化水,煎煮2-4小时,过滤得到滤液;合并提取液,浓缩至60-70℃相对密度为1.30-1.35的中药浸膏备用;
S4、往S3所得的中药浸膏中添加辅料,利用现代通用的制剂技术制成临床需要的成品制剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610196458.8A CN105727035A (zh) | 2016-03-31 | 2016-03-31 | 一种含艾叶的治疗结节性红斑的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610196458.8A CN105727035A (zh) | 2016-03-31 | 2016-03-31 | 一种含艾叶的治疗结节性红斑的中药组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105727035A true CN105727035A (zh) | 2016-07-06 |
Family
ID=56252623
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610196458.8A Pending CN105727035A (zh) | 2016-03-31 | 2016-03-31 | 一种含艾叶的治疗结节性红斑的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105727035A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101584773A (zh) * | 2009-06-10 | 2009-11-25 | 张学贵 | 一种治疗皮肤病的中草药 |
CN104523944A (zh) * | 2015-01-06 | 2015-04-22 | 中国人民解放军第二军医大学 | 一种治疗湿疹的中药及其应用 |
-
2016
- 2016-03-31 CN CN201610196458.8A patent/CN105727035A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101584773A (zh) * | 2009-06-10 | 2009-11-25 | 张学贵 | 一种治疗皮肤病的中草药 |
CN104523944A (zh) * | 2015-01-06 | 2015-04-22 | 中国人民解放军第二军医大学 | 一种治疗湿疹的中药及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105012392A (zh) | 一种用于治疗鼻炎的中药组合物及其制备方法 | |
CN105878927A (zh) | 一种制备治疗痔疮的药物组合物的方法 | |
CN104940485A (zh) | 一种治疗小儿哮喘的中药组合物及其制备方法 | |
CN104491384A (zh) | 一种治疗慢性咽炎的药物及其制备方法 | |
CN100386106C (zh) | 一种治疗痤疮的药物及其制备方法 | |
CN103083616B (zh) | 一种治疗卵巢囊肿的中药 | |
CN104984296A (zh) | 一种治疗女性更年期综合症的药物组合物及其制备方法 | |
CN103720762A (zh) | 治疗鼻炎蒸熏剂及其制备方法 | |
CN102670919A (zh) | 一种治疗慢性肾盂肾炎的中药 | |
CN103656537B (zh) | 一种治疗肺炎的中药 | |
CN102727676A (zh) | 一种治疗过敏性紫癜的中药组合物及其制备方法和用途 | |
CN102370853A (zh) | 一种治疗慢性肾盂肾炎的中药 | |
CN105343847A (zh) | 一种含有艾叶的治疗湿疹的中药组合物及其制备方法 | |
CN112316034A (zh) | 一种用于治疗慢性咽炎的外敷中药组合物及制备方法和应用 | |
CN105213609A (zh) | 一种治疗褥疮的中药组合物及其制备方法 | |
CN105343313A (zh) | 一种治疗老年性皮肤瘙痒症的中药组合物及其制备方法 | |
CN104771516A (zh) | 一种治疗过敏性皮炎的中药组合物 | |
CN105727035A (zh) | 一种含艾叶的治疗结节性红斑的中药组合物及其制备方法 | |
CN110496199B (zh) | 一种治疗牛皮癣的药物及其制备方法 | |
CN103432333B (zh) | 一种治疗甲状腺机能减退症的中药有效部位组合物 | |
CN101983676A (zh) | 一种妇科血瘀气滞疗剂 | |
CN104257875A (zh) | 用于妇女急性乳腺炎护理的外用中药组合物 | |
CN104800688A (zh) | 一种治疗慢性肾炎的中药组合物及应用 | |
CN104983982A (zh) | 一种治疗痔疮的中药组合物及其制备方法 | |
CN104922279A (zh) | 一种治疗慢性鼻炎的外用中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160706 |
|
RJ01 | Rejection of invention patent application after publication |